EVOTEC SEINH O.N. news, videos and press releases - Page 2
For more news please use our advanced search feature.
EVOTEC SEINH O.N. - More news...
EVOTEC SEINH O.N. - More news...
- EQS-News: Evotec SE to announce results for first quarter 2024 on 22 may 2024
- Evotec SE to Announce Results for First Quarter 2024 on 22 May 2024
- EQS-News: Bayer and Evotec collaborate to advance precision cardiology
- Bayer and Evotec Collaborate to Advance Precision Cardiology
- EQS-News: Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth
- Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth
- EQS-News: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
- EQS-Adhoc: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
- Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
- EQS-News: Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments
- EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
- Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
- EQS-News: Evotec SE to announce results for fiscal year 2023 on 24 April 2024
- Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024
- EQS-News: Evotec welcomes Aurélie Dalbiez as Chief People Officer
- Evotec welcomes Aurélie Dalbiez as Chief People Officer
- EQS-News: Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic
- Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic
- EQS-News: Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV
- Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV
- EQS-News: Evotec SE: Invitation to Conference Call
- Evotec SE: Invitation to Conference Call
- EQS-News: Evotec and Crohn´s & Colitis Foundation enter agreement to advance drug discovery for novel IBD therapies
- Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies
- EQS-News: Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb
- Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
- EQS-News: Evotec and Owkin enter an A.I.-powered strategic partnership to accelerate therapeutics pipeline in oncology and I&I
- Evotec and Owkin Enter an A.I.-Powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I
- EQS-News: Evotec announces CEO transition
- EQS-Adhoc: Evotec announces CEO transition